trans
company
trans
contact
impressum
legal notice
print this page
BioSolveIT
The Premier Scientific Solution Provider
BioSolveIT GmbH, the custom scientific software development company for virtual screening and lead discovery offers tools, services, and research collaborations. With a stellar scientific advisory board and founders from academia who intensely collaborate with pharma, BioSolveIT catalyzes products off of university research successes with proven pharmaceutical industry application. BioSolveIT provides world-renowned software products within the areas of ligand and structure-based drug design and is the pioneer of computational fragment-based ligand design. BioSolveIT innovate break-throughs in drug discovery by supplying smooth, user-centered designed tools bringing different researchers together for efficient multidisciplinary drug design.

Milestones of the company history:
2010
March    Release of a set of world class fragments for FBLD
January    Official release of LeadIT an integrated platform for docking, rescaffolding and FBLD
 
2009
December    Major update of free KNIME®- and Pipeline Pilot® components available
May    CloudScientific appoited as distributor for China
March    KnowledgeSpace Release, data for designing synthetic molecules
Febuary    Publication of FTrees fragment searching success from BI collaboration
 
2008
December    leadership forged in FBLD with: ReCore, CoLibri, FTrees-FS, and FlexNovo
October    release of FlexX 3.1 including improved water and metal handling
September    Pipeline Pilot® interfaces for FlexX, FlexS and FTrees released
June - August    Inforsense China Ltd. and Apsara Innovations Pvt. Ltd. appointed distributors
March - May    leadership in fragment based design software: ReCore, CoLibri, FTreesXL, and FlexNovo
February    government funding for the development of fragment-based computer methods
January    virtual screening browser FTreesXL with new FTrees release 2 out
 
2007    exclusive distribution partnership with Ryoka Systems Japan concluded
2006    partnership with CCG, release of MOE®-compatible FlexX
2005    major version FlexX Release 2 out
2004    government funding for the development of the next-generation fragment based design software
2003    numerous collaborative development partnerships with big pharma
2002    release of a revolutionary approach to pharmacophore-based docking: FlexX-Pharm
2001    company foundation

Last modified Monday, 05. Jul 2010 13:57 CEST by WebMaster